Agios Pharmaceuticals, Inc.
2.6M
$1.59B
-3.82
$-7.12
No price alerts set. Add an alert to get notified!
-3.82
1.32
$-7.12
-34.60%
-764.01%
-873.87%
Compare TSM with similar companies in the sector
| Company | Price | Change % | P/E | Market Cap | D/E |
|---|---|---|---|---|---|
|
BEAM
Beam Therapeutics Inc.
|
$31.04 | -1.12% | -39.92 | $3.17B | 0.24 |
|
COGT
Cogent Biosciences, Inc.
|
$37.50 | 0.67% | -7.71 | $6.09B | 0.40 |
|
DNLI
Denali Therapeutics Inc.
|
$20.80 | 1.12% | -7.12 | $3.31B | 0.04 |
|
ETNB
89bio, Inc.
|
$14.84 | 0.00 | -7.78 | $2.20B | 0.07 |
|
GLPG
Galapagos N.V.
|
$29.31 | 0.10% | 5.13 | $1.93B | 0.00 |
|
IBRX
ImmunityBio, Inc.
|
$8.19 | 6.36% | -23.07 | $8.42B | -1.76 |
|
LQDA
Liquidia Corporation
|
$37.75 | -4.37% | -47.70 | $3.33B | 4.42 |
|
RCUS
Arcus Biosciences, Inc.
|
$22.98 | -5.24% | -6.99 | $2.31B | 0.16 |
|
RXRX
Recursion Pharmaceuticals, Inc.
|
$3.70 | -2.12% | -3.02 | $1.66B | 0.07 |
|
SRPT
Sarepta Therapeutics, Inc.
|
$21.25 | -1.39% | -3.12 | $2.23B | 0.91 |
* Peer stocks are selected based on market capitalization and sector
$46.00
$22.24
$0.00
0.00%
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
